Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.9950 (0.23%) ($12.9950 - $12.9950) on Tue. Jun. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.25% (three month average) | RSI | 72 | Latest Price | $12.9950(0.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.7% a day on average for past five trading days. | Weekly Trend | FOLD advances 6.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(62%) IBB(57%) IWO(42%) IWM(41%) IWN(38%) | Factors Impacting FOLD price | FOLD will decline at least -1.125% in a week (0% probabilities). TBT(-32%) UUP(-15%) VXX(-11%) BNDX(-2%) VIXM(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.125% (StdDev 2.25%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.81(1.44%) | 10 Day Moving Average | $12.39(4.88%) | 20 Day Moving Average | $11.91(9.11%) | To recent high | 0% | To recent low | 20.9% | Market Cap | $3.356b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |